Zerumbone Promotes Cytotoxicity in Human Malignant Glioblastoma Cells through Reactive Oxygen Species (ROS)‎ Generation

Abstract EN

Glioblastoma multiforme (GBM) is the most hostile tumor in the central nervous system.

Unfortunately, the prognosis of GBM patients is poor following surgical interventions, chemotherapy, and radiotherapy.

Consequently, more efficient and effective treatment options for the treatment of GBM need to be explored.

Zerumbone, as a sesquiterpene derived from Zingiber zerumbet Smith, has substantial cytotoxic and antiproliferative activities in some types of cancer.

Here, we show that exposure of GBM cells (U-87 MG) to Zerumbone demonstrated significant growth inhibition in a concentration-dependent manner.

Zerumbone also induced apoptosis and caused cell cycle arrest of human GBM U-87 MG cells in the G2/M phase of the cell cycle.

In detail, the apoptotic process triggered by Zerumbone involved the upregulation of proapoptotic Bax and the suppression of antiapoptotic Bcl-2 genes expression as determined by qRT-PCR.

Moreover, Zerumbone enhanced the generation of reactive oxygen species (ROS), and N-acetyl cysteine (NAC), as an antioxidant, reversed the ROS-induced cytotoxicity of U-87 MG cells.

The Western blot analysis suggested that Zerumbone activated the NF-κB p65, which was partly inhibited by NAC treatment.

Collectively, our results confirmed that Zerumbone induces cytotoxicity by ROS generation.

Thus, the study raises the possibility of Zerumbone as a potential natural agent for treating GBM due to its ability to induce cytotoxicity.